Does UPADACITINIB Cause Covid-19 pneumonia? 141 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 141 reports of Covid-19 pneumonia have been filed in association with UPADACITINIB (Rinvoq). This represents 0.2% of all adverse event reports for UPADACITINIB.
141
Reports of Covid-19 pneumonia with UPADACITINIB
0.2%
of all UPADACITINIB reports
21
Deaths
123
Hospitalizations
How Dangerous Is Covid-19 pneumonia From UPADACITINIB?
Of the 141 reports, 21 (14.9%) resulted in death, 123 (87.2%) required hospitalization, and 4 (2.8%) were considered life-threatening.
Is Covid-19 pneumonia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UPADACITINIB. However, 141 reports have been filed with the FAERS database.
What Other Side Effects Does UPADACITINIB Cause?
Pain (4,444)
Arthralgia (3,815)
Drug ineffective (3,384)
Covid-19 (2,978)
Rheumatoid arthritis (2,730)
Pain in extremity (2,353)
Fatigue (2,153)
Fall (2,081)
Surgery (2,037)
Therapy interrupted (1,741)
What Other Drugs Cause Covid-19 pneumonia?
RITUXIMAB (1,489)
DEXAMETHASONE (758)
LENALIDOMIDE (750)
PREDNISONE (749)
OCRELIZUMAB (669)
TACROLIMUS (622)
MYCOPHENOLATE MOFETIL (594)
PREDNISOLONE (479)
METHOTREXATE (472)
CYCLOPHOSPHAMIDE (430)
Which UPADACITINIB Alternatives Have Lower Covid-19 pneumonia Risk?
UPADACITINIB vs URAPIDIL
UPADACITINIB vs UREA
UPADACITINIB vs URIDINE TRIACETATE
UPADACITINIB vs UROFOLLITROPIN
UPADACITINIB vs URSODIOL